Tobacco Control Research Branch (TCRB)
Mission
The Tobacco Control Research Branch (TCRB) leads and collaborates on research and disseminates evidence-based findings to prevent, treat, and control tobacco use in order to create a world free of tobacco use and related cancer and suffering. TCRB is within the National Cancer Institute’s (NCI) Behavioral Research Program (BRP), in the Division of Cancer Control and Population Sciences (DCCPS).
Scientific Priorities
- Advertising and marketing of tobacco products
- Epidemiology and surveillance of tobacco knowledge, attitudes, and behavior
- Etiology, predictors, correlates, and determinants of tobacco use, nicotine dependence, and cessation
- Global tobacco control, especially in low- and middle-income countries
- Media and policy to reduce tobacco use
- Other tobacco products, e.g., smokeless tobacco, cigars, roll-your-own, hookah, bidis, etc.
- Potential Reduced-Exposure Tobacco Products (PREPs)
- Secondhand smoke
- Tobacco cessation interventions at the individual, system, and population levels
- Tobacco control interventions for underserved and at-risk populations
- Tobacco industry documents
- Tobacco prevention interventions at the individual, system, and population levels
- Tobacco product analysis, e.g., design and composition, constituents and additives, processing, manufacturing
- Tobacco use and cessation in cancer screening, diagnosis, treatment, and survivorship
- Tobacco-related disparities
News and Highlights
- Cigarette Smoking Among U.S. Adults Lowest Ever Recorded: 14% in 2017
CDC Press Release; MMWR report - Themed Issue on Eye Tracking (Tobacco Regulatory Science, November 2018)
- Vaping Pods Produce High Nicotine Levels in Young Users, Cancer Currents blog post
- New - CDC MMWR Report: State-Specific Prevalence of Tobacco Product Use Among Adults
- International Research in Tobacco Control factsheet (PDF, 993 KB), February 2018
- 2014-2015 TUS-CPS Highlights Document (PDF 1.5 MB)
Featured Funding Announcement
Improving Smoking Cessation Interventions among People Living with HIV (R01/R21 Clinical Trial Optional): RFA-CA-18-027/RFA-CA-18-028
See More AnnouncementsInitiatives and Measures
TCRB Grant Portfolio and Funding Opportunities
Featured Grantees
Resources
Meet Our Staff
Our team of accomplished scientists and research associates, fellows, and administrators is dedicated to advancing behavioral science research in cancer prevention and control.
TCRB Staff![staff photo](/congress115th/20190109024153im_/https://cancercontrol.cancer.gov/brp/images/staff-photo-TCRB.jpg)